GENE ONLINE|News &
Opinion
Blog

Go Prime
Special
EQRx, CStone’s Low-Cost anti-PD-L1 Inhibitor Flaunts Encouraging Data in Stage 3 NSCLC
2021-09-19
Special
Day 1 ESMO 2021 Roundup: Investigational Immunotherapies Show Promise in Early Cancer Trials
2021-09-18
Special
ESMO21: Experts Debate Whether MRD Diagnosis Can Improve Cure Rates in Solid Tumors
2021-09-17
Feature
Lilly, Innovent’s Tyvyt Registers Positive Outcomes in Esophageal and Gastric Cancer Trials
2021-09-17
Special Gene Therapy
Harnessing Viral Evolution to Deliver Gene Therapy to Specific Tissues
2021-09-13
Trials & Approvals Lung Cancer
NHS to Roll Out Revolutionary Lung Cancer Drug Targeting the Once ‘Undruggable’ KRAS
2021-09-12
Funding
Jennifer Doudna’s Gene Editing Firm Mammoth Biosciences Attains Unicorn Status
2021-09-11
Licensing RNA Editing
Eli Lilly Forays Into RNA Editing, Betting More than a Billion Dollars on ProQR’s Technology
2021-09-09
Novel Mutational Patterns Explain Evolution of Lung Cancer in Never-Smokers
2021-09-09
Licensing
Adaptimmune Therapeutics Breaks Rough Patch With New Multibillion-Dollar Collaboration
2021-09-08
Special Gene Editing
Researchers Engineer “Mini” CRISPR-Cas System That Could Act as ‘Swiss Army Knife’ for Mammalian Genome Editing
2021-09-07
Special AlphaFold
Artificial Intelligence Solves A Fifty Year Old Protein Folding Problem
2021-09-07
Trials & Approvals FDA Approval
BeiGene’s Brukinsa Bags Second FDA Approval, to Rival Imbruvica in Treating a Rare Cancer
2021-09-06
Special RNA Editing
Feng Zhang’s Team Engineer “Ultra-Compact” Cas-13 To Solve Packaging and Delivery Issues of RNA Editors
2021-09-05
COVID-19 DNA Vaccine
Why Are Human DNA Vaccines Such a Big Deal?
2021-09-02
1 … 4 5 6 7 8 … 11
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top